| Ident. | Authors (with country if any) | Title |
|---|
| 000039 (2020) |
Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine] | [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. |
| 000062 (2020) |
Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine] | Why tocilizumab could be an effective treatment for severe COVID-19? |
| 000099 (2020) |
Yong Xiong [République populaire de Chine] ; Yuan Liu [République populaire de Chine] ; Liu Cao [République populaire de Chine] ; Dehe Wang [République populaire de Chine] ; Ming Guo [République populaire de Chine] ; Ao Jiang [République populaire de Chine] ; Dong Guo [République populaire de Chine] ; Wenjia Hu [République populaire de Chine] ; Jiayi Yang [République populaire de Chine] ; Zhidong Tang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Yongquan Lin [République populaire de Chine] ; Meiyuan Zhang [République populaire de Chine] ; Qi Zhang [République populaire de Chine] ; Mang Shi [République populaire de Chine] ; Yingle Liu [République populaire de Chine] ; Yu Zhou [République populaire de Chine] ; Ke Lan [République populaire de Chine] ; Yu Chen [République populaire de Chine] | Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. |
| 000122 (2020) |
Qing Ye [République populaire de Chine] ; Bili Wang [République populaire de Chine] ; Jianhua Mao [République populaire de Chine] | The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. |
| 000148 (2020) |
Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie] | The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 |
| 000151 (2020) |
Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine] | The Science Underlying COVID-19: Implications for the Cardiovascular System. |
| 000158 (2020) |
Peter J. Hotez ; Maria Elena Bottazzi ; David B. Corry | The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |
| 000321 (2020) |
Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie] | Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |
| 000444 (2020) |
Arinjay Banerjee [Canada] ; Michelle L. Baker [Australie] ; Kirsten Kulcsar [États-Unis] ; Vikram Misra [Canada] ; Raina Plowright [États-Unis] ; Karen Mossman [Canada] | Novel Insights Into Immune Systems of Bats |
| 000496 (2020) |
Tiago Torres [Portugal] ; Luis Puig [Espagne] | Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic |
| 000506 (2020) |
Li Runfeng [République populaire de Chine] ; Hou Yunlong [République populaire de Chine] ; Huang Jicheng [République populaire de Chine] ; Pan Weiqi [République populaire de Chine] ; Ma Qinhai [République populaire de Chine] ; Shi Yongxia [République populaire de Chine] ; Li Chufang [République populaire de Chine] ; Zhao Jin [République populaire de Chine] ; Jia Zhenhua [République populaire de Chine] ; Jiang Haiming [République populaire de Chine] ; Zheng Kui [République populaire de Chine] ; Huang Shuxiang [République populaire de Chine] ; Dai Jun [République populaire de Chine] ; Li Xiaobo [République populaire de Chine] ; Hou Xiaotao [République populaire de Chine] ; Wang Lin [République populaire de Chine] ; Zhong Nanshan [République populaire de Chine] ; Yang Zifeng [République populaire de Chine] | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). |
| 000521 (2020) |
Maryam Fattahian [Iran] ; Mustafa Ghanadian [Iran] ; Zulfiqar Ali [États-Unis] ; Ikhlas A. Khan [États-Unis] | Jatrophane and rearranged jatrophane-type diterpenes: biogenesis, structure, isolation, biological activity and SARs (1984-2019). |
| 000536 (2020) |
M. Bizzarri [Italie] ; A S Laganà ; D. Aragona ; V. Unfer | Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2? |
| 000546 (2020) |
Gionata Fiorino [Italie] ; Mariangela Allocca [Italie] ; Federica Furfaro [Italie] ; Daniela Gilardi [Italie] ; Alessandra Zilli [Italie] ; Simona Radice [Italie] ; Antonino Spinelli [Italie] ; Silvio Danese [Italie] | Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience. |
| 000551 (2020) |
P. Conti [Italie] ; G. Ronconi [Italie] ; A. Caraffa [Italie] ; C. Gallenga [Italie] ; R. Ross [États-Unis] ; I. Frydas [Grèce] ; S. Kritas [Grèce] | Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. |
| 000586 (2020) |
P. Conti [Italie] ; C E Gallenga [Italie] ; G. Tetè [Italie] ; Al Caraffa [Italie] ; G. Ronconi [Italie] ; A. Younes [Italie] ; E. Toniato [Italie] ; R. Ross [États-Unis] ; S K Kritas [Grèce] | How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. |
| 000602 (2020) |
Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
| 000648 (2020) |
Marco Malavolta [Italie] ; Robertina Giacconi [Italie] ; Dario Brunetti [Italie] ; Mauro Provinciali [Italie] ; Fabrizio Maggi [Italie] | Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats. |
| 000676 (2020) |
Marietta Iacucci [Royaume-Uni, Canada] ; Rosanna Cannatelli [Royaume-Uni, Italie] ; Nunzia Labarile [Royaume-Uni, Italie] ; Ren Mao [République populaire de Chine, États-Unis] ; Remo Panaccione [Canada] ; Silvio Danese [Italie] ; Gursimran S. Kochhar [États-Unis] ; Subrata Ghosh [Royaume-Uni, Canada] ; Bo Shen [États-Unis] | Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period |
| 000747 (2020) |
Md Insiat Islam Rabby [Malaisie] | Current Drugs with Potential for Treatment of COVID-19: A Literature Review. |
| 000787 (2020) |
P. Conti [Italie] ; A. Younes [Italie] | Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
